These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 28630381)
21. [Expression and immunogenicity evaluation of ectodomain and subdomains of Plasmodium berghei apical membrane antigen 1]. Li SL; Zhang DM; Cao Y; Pan WQ Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Feb; 25(1):1-5. PubMed ID: 17639690 [TBL] [Abstract][Full Text] [Related]
22. In vitro assessment of the effects of anti-HER2 monoclonal antibodies on proliferation of HER2-overexpressing breast cancer cells. Tahmasebi F; Kazemi T; Amiri MM; Khoshnoodi J; Mahmoudian J; Bayat AA; Jeddi-Tehrani M; Rabbani H; Shokri F Immunotherapy; 2014; 6(1):43-9. PubMed ID: 24341883 [TBL] [Abstract][Full Text] [Related]
23. Small sized EGFR1 and HER2 specific bifunctional antibody for targeted cancer therapy. Ding L; Tian C; Feng S; Fida G; Zhang C; Ma Y; Ai G; Achilefu S; Gu Y Theranostics; 2015; 5(4):378-98. PubMed ID: 25699098 [TBL] [Abstract][Full Text] [Related]
24. Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility. Ghedini GC; Ciravolo V; Tortoreto M; Giuffrè S; Bianchi F; Campiglio M; Mortarino M; Figini M; Coliva A; Carcangiu ML; Zambetti M; Piazza T; Ferrini S; Ménard S; Tagliabue E; Pupa SM J Cell Physiol; 2010 Oct; 225(1):256-65. PubMed ID: 20506359 [TBL] [Abstract][Full Text] [Related]
25. Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu. Mohanty K; Saha A; Pal S; Mallick P; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M Breast Cancer Res Treat; 2007 Jul; 104(1):1-11. PubMed ID: 17004107 [TBL] [Abstract][Full Text] [Related]
26. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice]. Cao Y; Zhang DM; Pan WQ Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293 [TBL] [Abstract][Full Text] [Related]
27. [Cytotoxic activity of spleen lymphocytes in BALB/c mice immunized by HSP110-HER2/neu ICD]. Han D; Xu H; Yan WQ Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):11-4. PubMed ID: 22490848 [TBL] [Abstract][Full Text] [Related]
28. Rigidity of the extracellular part of HER2: Evidence from engineering subdomain interfaces and shared-helix DARPin-DARPin fusions. Jost C; Stüber JC; Honegger A; Wu Y; Batyuk A; Plückthun A Protein Sci; 2017 Sep; 26(9):1796-1806. PubMed ID: 28639341 [TBL] [Abstract][Full Text] [Related]
29. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice. Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156 [TBL] [Abstract][Full Text] [Related]
30. Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion protein. Zhang DX; Zhao PT; Xia L; Liu LL; Liang J; Zhai HH; Zhang HB; Guo XG; Wu KC; Xu YM; Jia LT; Yang AG; Chen SY; Fan DM Gut; 2010 Mar; 59(3):292-9. PubMed ID: 19951902 [TBL] [Abstract][Full Text] [Related]
31. Antitumor effect of new HER2 peptide vaccination based on B cell epitope. Miyako H; Kametani Y; Katano I; Ito R; Tsuda B; Furukawa A; Saito Y; Ishikawa D; Ogino K; Sasaki S; Imai K; Habu S; Makuuchi H; Tokuda Y Anticancer Res; 2011 Oct; 31(10):3361-8. PubMed ID: 21965747 [TBL] [Abstract][Full Text] [Related]
32. ErbB receptor activation, cell morphology changes, and apoptosis induced by anti-Her2 monoclonal antibodies. Kita Y; Tseng J; Horan T; Wen J; Philo J; Chang D; Ratzkin B; Pacifici R; Brankow D; Hu S; Luo Y; Wen D; Arakawa T; Nicolson M Biochem Biophys Res Commun; 1996 Sep; 226(1):59-69. PubMed ID: 8806592 [TBL] [Abstract][Full Text] [Related]
33. Differential tumor inhibitory effects induced by HER3 extracellular subdomain-specific mouse monoclonal antibodies. Hassani D; Jeddi-Tehrani M; Yousefi P; Mansouri-Fard S; Mobini M; Ahmadi-Zare H; Golsaz-Shirazi F; Amiri MM; Shokri F Cancer Chemother Pharmacol; 2022 Mar; 89(3):347-361. PubMed ID: 35079876 [TBL] [Abstract][Full Text] [Related]
34. Inhibitory Effect of Polyclonal Antibodies Against HER3 Extracellular Subdomains on Breast Cancer Cell Lines. Mansouri-Fard S; Ghaedi M; Shokri MR; Bahadori T; Khoshnoodi J; Golsaz-Shirazi F; Jeddi-Tehrani M; Amiri MM; Shokri F Asian Pac J Cancer Prev; 2020 Feb; 21(2):439-447. PubMed ID: 32102522 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu. Jasinska J; Wagner S; Radauer C; Sedivy R; Brodowicz T; Wiltschke C; Breiteneder H; Pehamberger H; Scheiner O; Wiedermann U; Zielinski CC Int J Cancer; 2003 Dec; 107(6):976-83. PubMed ID: 14601058 [TBL] [Abstract][Full Text] [Related]
36. Antibody-mediated targeting of replication-competent retroviral vectors. Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141 [TBL] [Abstract][Full Text] [Related]
37. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins]. Ma SD; Luo RC; Ding ZH; Lu F; Yuan CQ Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1184-7. PubMed ID: 16939917 [TBL] [Abstract][Full Text] [Related]
38. Bispecific anti-HER2 and CD16 single-chain antibody production prolongs the use of stem cell-like cell transplantation against HER2-overexpressing cancer. Kasuya K; Shimazu M; Suzuki M; Itoi T; Aoki T; Tsuchida A Int J Mol Med; 2010 Feb; 25(2):209-15. PubMed ID: 20043129 [TBL] [Abstract][Full Text] [Related]
39. [Eukaryotic expression and biological activities of anti-p185 erbB2 mouse/human chimeric antibody]. Jiang BH; Liu WB; Meng L; Wu J; Shou CC Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):491-5. PubMed ID: 15489929 [TBL] [Abstract][Full Text] [Related]
40. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma. Mayevska O; Shuvayeva H; Igumentseva N; Havrylov S; Basaraba O; Bobak Y; Barska M; Volod'ko N; Baranska J; Buchman V; Drobot L Exp Oncol; 2006 Dec; 28(4):275-81. PubMed ID: 17285110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]